Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening

被引:40
作者
Cheng, CC
Bahado-Singh, RO
Chen, SC
Tsai, MS [1 ]
机构
[1] Cathay Gen Hosp, Prenatal Diag Ctr, Taipei, Taiwan
[2] Cathay Gen Hosp, Dept Obstet Gynecol, Taipei, Taiwan
[3] Univ Cincinnati, Div MFM, Dept Obstet Gynecol, Cincinnati, OH 45221 USA
关键词
ultrasonography; nuchal translucency; adverse outcome; first-trimester Down syndrome screening;
D O I
10.1016/S0020-7292(03)00206-6
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: The purpose of this study was to evaluate the outcomes of pregnancies with nuchal translucency greater or equal to 3 mm for routine first trimester screening in unselected populations. Methods: A total of 2980 pregnant women for first trimester ultrasonography were routinely offered crown-rump length (CRL) and nuchal translucency (NT) for screening for Down syndrome between 11 and 14 weeks' gestation. A complete follow-up was obtained in all cases by a review of medical records. Results: Using a cut-off value of 3 mm, the prevalence of increased fetal NT was 0.7% (n = 22). Among the 22 cases, there were five (22.7%) chromosomal abnormalities. Of the 17 chromosomally normal pregnancies, four resulted in fetal demise (spontaneous abortion, intrauterine death or termination of pregnancy due to fetal abnormalities). The remaining 13 pregnancies resulted in live births, including one gestational hypertension and one preterm delivery, respectively. The total incidence of an adverse outcome in the group of increased fetal NT was 45.5%. Conclusions: In a routine population with first-trimester ultrasonography, fetal NT measuring greater than or equal to 3 mm was associated with a poor pregnancy outcome with not only chromosomal abnormalities and congenital cardiac diseases, but also poor maternal and fetal health or adverse pregnancy outcomes. In addition, this study also demonstrated the necessity for fetal assessment and follow-up in cases where the fetal NT is increased in the first trimester. (C) 2003 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:5 / 9
页数:5
相关论文
共 19 条
[1]   Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population [J].
Adekunle, O ;
Gopee, A ;
El-Sayed, M ;
Thilaganathan, B .
BRITISH JOURNAL OF RADIOLOGY, 1999, 72 (857) :457-460
[2]   Outcome of fetuses with enlarged nuchal translucency and normal karyotype [J].
Bilardo, CM ;
Pajkrt, E ;
de Graaf, I ;
Mol, BW ;
Bleker, OP .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1998, 11 (06) :401-406
[3]   Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation [J].
Brady, AF ;
Pandya, PP ;
Yuksel, B ;
Greenough, A ;
Patton, MA ;
Nicolaides, KH .
JOURNAL OF MEDICAL GENETICS, 1998, 35 (03) :222-224
[4]  
Chaban FK, 1996, PRENATAL DIAG, V16, P537, DOI 10.1002/(SICI)1097-0223(199606)16:6<537::AID-PD911>3.0.CO
[5]  
2-4
[6]   The prognosis of fetuses with transient nuchal translucency in the first and early second trimester [J].
Fukada, Y ;
Yasumizu, T ;
Takizawa, M ;
Amemiya, A ;
Hoshi, K .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1997, 76 (10) :913-916
[7]   Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks [J].
Matias, A ;
Huggon, I ;
Areias, JC ;
Montenegro, N ;
Nicolaides, KH .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1999, 14 (05) :307-310
[8]   Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects [J].
Mavrides, E ;
Cobian-Sanchez, F ;
Tekay, A ;
Moscoso, G ;
Campbell, S ;
Thilaganathan, B ;
Carvalho, JS .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 17 (02) :106-110
[9]   Pregnancy outcome and infant follow-up of fetuses with abnormally increased first trimester nuchal translucency [J].
Maymon, R ;
Jauniaux, E ;
Cohen, O ;
Dreazen, E ;
Weinraub, Z ;
Herman, A .
HUMAN REPRODUCTION, 2000, 15 (09) :2023-2027
[10]  
Pajkrt E, 1999, PRENATAL DIAG, V19, P1104, DOI 10.1002/(SICI)1097-0223(199912)19:12<1104::AID-PD707>3.0.CO